Valeant sells manufacturing facility in Poland

By Elaine Rigoli

Tampa, Fla., May 18 - Valeant Pharmaceuticals International has sold its manufacturing facility in Warsaw, Poland, to Strides Polska Sp. zoo. Details of the transaction were not disclosed.

"The Warsaw plant sale is another step forward in the execution of our manufacturing improvement plan. We continue to make excellent progress in the rationalization of our network, which we believe will assure the achievement of our goal to reduce cost of goods sold to 20% to 25% by 2008," president and chief executive officer Timothy C. Tyson said in a news release.

Located in Costa Mesa, Calif., Valeant is a science-based specialty pharmaceutical company that develops products in the areas of neurology, infectious disease and dermatology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.